NFAT3 Antibody [H15F22]

N° de catalogue F4697

Imprimer

Description biologique

Spécificité NFAT3 Antibody [H15F22] détecte les niveaux endogènes de protéine NFAT3 totale.
Contexte NFAT3 (NFATc4), un facteur de transcription de la famille des facteurs nucléaires des lymphocytes T activés (NFAT) principalement exprimé dans les lymphocytes T, les lymphocytes B et les myocytes cardiaques, contient un domaine régulateur N-terminal intrinsèquement désordonné avec des régions riches en sérine (SRR) et des motifs répétés SP qui servent de sites de liaison à la calcineurine, une région centrale d'homologie Rel (RHR) repliée comme une immunoglobuline avec un domaine de liaison à l'ADN reconnaissant les séquences consensus GGAAA et un signal de localisation nucléaire (NLS), et un domaine de transactivation C-terminal (TAD) qui recrute les coactivateurs CBP/p300. Lors de la stimulation du récepteur des cellules T (TCR) ou du GPCR, l'augmentation du Ca2+ cytosolique active la calcineurine liée à la calmoduline, qui déphosphoryle 14 résidus de sérine conservés dans les régions SRR/SP, exposant le NLS et permettant la translocation nucléaire de NFAT3. Dans le noyau, NFAT3 s'homodimérise ou coopère avec des partenaires comme AP-1 (c-Fos/c-Jun), GATA3 ou MEF2 pour transactiver les gènes de cytokines (IL-2, IL-4, TNF-α) et FasL au niveau de sites composites NFAT:AP-1, tandis que dans les cardiomyocytes, il conduit à une hypertrophie pathologique en induisant l'expression des gènes BNP et MHCα. L'export nucléaire et la séquestration cytoplasmique sont restaurés par rephosphorylation via GSK3β, CK1 ou PKA. De manière unique, NFAT3 réprime la progression du cycle cellulaire et favorise l'apoptose dans les neurones via l'induction de Trim17, contrairement au rôle pro-mort de NFAT4 ; une déficience en NFAT3 altère la différenciation Th2 et les réponses IgE. L'hyperactivation nucléaire dérégulée de NFAT3 contribue à l'inflammation synoviale de la polyarthrite rhumatoïde, à l'hypertrophie et à l'insuffisance cardiaque sous surcharge de pression, et aux lymphomes à cellules B via la signalisation constitutive d'IL-2.

Informations dutilisation

Application WB Dilution
WB
1:1000
Réactivité Human, Mouse, Rat
Source Rabbit Monoclonal Antibody MW 120-140 kDa
Tampon de stockage PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Stockage
(À partir de la date de réception)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Références

  • https://pubmed.ncbi.nlm.nih.gov/9143705/
  • https://pubmed.ncbi.nlm.nih.gov/27100893/

Données dapplication

WB

Validé par Selleck

  • F4697-wb
    Lane 1: A204, Lane 2: A10, Lane 3: Hela